Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 817 results for "gsk consumer"

Novartis okays OTC unit sale to GSK Consumer for Rs109.7-crore

Novartis okays OTC unit sale to GSK Consumer for Rs 109.7-cr

Novartis India's board today approved the sale of its OTC division to GlaxoSmithKline Consumer Pvt Ltd, a consumer healthcare joint venture between Novartis AG and GSK, for a consideration of Rs 109.7 crore. The move follows a global deal struck in ... Business Standard, 2 weeks ago

6 images for gsk consumer

MarketingWorld, 1 week ago, 2 weeks ago
Pharmaceutical Technology, 1 week ago
Pharmaceutical Business Review, 1 week ago
Business Standard, 2 weeks ago
This Day Online, 1 week ago
Business Standard

GSK eyes up to 35 percent growth in RI market

With its new products, global consumer healthcare manufacturer GlaxoSmithKline (GSK) is upbeat that the company's annual sales growth can reach more than 30 percent in the growing Indonesian healthcare market over the coming years. GSK Indonesia ...
 Jakarta Post6 days ago Prashant Pandey is Marketing Director of GSK Consumer Healthcare  EHealth Magazine1 month ago Prashant Pandey takes over as Marketing Director for GSK Consumer Healthcare Jayant Singh to lead the Brazil business for the company  Agencyfaqs!1 month ago Jayant+Singh+to+lead+the+Brazil+business+for+the+company">Prashant Pandey takes over as Marketing Director for GSK Consumer Healthcare Jayant Singh to lead the Brazil business for the company  Agencyfaqs!1 month ago
Business Standard

Boosts new anthem Hey Champion Stay Champion

As the cricket fervor catches up with fans, GSK Consumer Healthcare's health food drink Boost has launched a new anthem to cheer the Boost heroes. Composed and sung by the talented music director G.V. Prakash, Hey Champion Stay Champion is an ...
 APN News1 week ago Consumer Cos may report higher gross margins: P Lilladher  Moneycontrol.com1 month ago GSK Consumer Healthcare edges up after decent quarterly earnings  Business Standard2 months ago GSK standalone net up 9% in July-Sept quarter  Business Standard2 months ago


The board of Novartis India has approved the transfer of its over-the- counter (OTC) business to GlaxoSmithKline Consumer Pvt Ltd (GSK) for Rs109 crore . The company is waiting for the regulatory approvals to complete the deal. Novartis , GSK ...
 4 Traders1 week ago
Business Standard

Novartis India to sell OTC business to GSK Consumer for Rs 109 cr

Shares of the company went down by 0.45% to close at Rs 672.4 on BSE BS Reporter | Mumbai January 13, 2015 Last Updated at 19:14 IST Novartis will sell its Over-The-Counter Division (OTC Division) of Indian arm to GlaxoSmithKline Consumer Private Limited, ...
 Business Standard2 weeks ago NOVARTIS INDIA : to sell OTC business to GSK Consumer for $17.6m  4 Traders1 week ago Novartis to sell OTC business to GSK Consumer for $17.6m  Pharmaceutical Business Review1 week ago GSK to pick up with new drugs  Business Quarter2 weeks ago

Novartis India rises on plan to sell OTC business to GSK Consumer for Rs 109 crore

Novartis India is currently trading at Rs. 677.80, up by 5.40 points or 0.80% from its previous closing of Rs. 672.40 on the BSE. The scrip opened at Rs. 680.00 and has touched a high and low of Rs. 680.00 and Rs. 674.00 respectively. So far 10612 ...
 Arihant Capital1 week ago
Nigerian Tribune

GSK Outlines Challenges Facing Panadol Brand

THE Marketing Director of GlaxoSmithKline Consumer Nigeria Plc, Kerry Alexander, has identified increased competition, generic, counterfeiting and poor distribution network as some of the reasons for the lull of the Panadol brand in the Nigerian ...
 The Guardian Nigeria3 days ago GSK Nigeria launches new product for children  Nigerian Tribune1 week ago Nigeria: GSK Launches New Panadol for Children  AllAfrica.com5 days ago GSK Launches New Panadol for Children  This Day Online1 week ago

FTC Approves Novartis/GSK OTC Venture But Novartis Must Divest Nicotine Patch Biz

The Federal Trade Commission has finally approved the joint venture between Novartis AG and GlaxoSmithKline in consumer health products, but Novartis must divest its Habitrol line of nicotine patches. As per the April 2014 agreement , Novartis ...
 Pharmaceutical Manufacturing Magazine4 days ago FTC Approves Novartis-GSK Deal; Former Asked to Divest Nicotine Patch Business  Bidness Etc5 days ago

Glaxo CEO: Consumer health IPO may be in our future

GlaxoSmithKline CEO Andrew Witty When GlaxoSmithKline's ($GSK) multi-billion asset swap with Novartis ($NVS) closes this year, don't expect the British pharma giant to stop there, its CEO says--especially when it comes to consumer health. Once ...
 FiercePharma1 week ago GlaxoSmithKline rejected e-cig buy to beef up stop-smoking franchise  FiercePharma1 week ago

GSK Consumer Nigeria Unveils New Drugs For Children

GlaxoSmithKline Consumer Nigeria Plc (GSK), has introduced its Panadol Children's suspension and Scott's Cod Liver Oil Emulsion for kids to healthcare professionals (HCPs) at an event held recently in Lagos. Those in attendance at the event ...
 MarketingWorld1 week ago GSK unveils panadol, Scott cod liver oil emulsion for kids  The Nation Nigeria1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less